George H. Talbot
Madison Group (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy, Pneumonia and Respiratory Infections, Bacterial Identification and Susceptibility Testing, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America(2008)4,909 cited
- → Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America(2006)1,103 cited
- → 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America(2013)693 cited
- → Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection(2014)422 cited
- → Risk factors for nosocomial candidemia: A case-control study in adults without leukemia(1989)276 cited
- → Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection(2010)236 cited